Celgene Says 9th Circ. Ruling Means $40B FCA Suit Must Go
By Daniel Siegal ( January 31, 2017, 5:01 PM EST) -- Celgene on Monday urged a California federal judge to reconsider his refusal to throw out a $40 billion False Claims Act suit accusing the pharmaceutical company of overcharging Medicare and Medicaid for cancer drugs, arguing that a recent Ninth Circuit ruling requires the court to apply a legal standard the relator cannot satisfy....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.